The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.
Section 3. Summaries of Infectious Diseases
Smallpox (Variola)
In 1979, the World Health Organization declared that smallpox (variola) had been eradicated successfully worldwide. The last naturally occurring case of smallpox occurred in Somalia in 1977, followed by 2 cases attributable to laboratory exposure in 1978. The United States discontinued routine childhood immunization against smallpox in 1972 and routine immunization of health care professionals in 1976. The US military continued to immunize military personnel until 1995. Since 1980, the vaccine has been recommended only for people working with nonvariola orthopoxviruses. Two World Health Organization reference laboratories were authorized to maintain stocks of variola virus. There is concern that the virus and the expertise to use it as a weapon of bioterrorism may have been misappropriated.
Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
CLINICAL MANIFESTATIONS: An individual infected with variola
major develops a severe prodromal illness characterized by high
fever (102°F104°F [38.9°C40.0°C])
and constitutional symptoms, including malaise, severe headache,
backache, abdominal pain, and prostration, lasting for 2 to
5 days. Abdominal pain and back pain may be mistaken for focal
pathology. Infected children may suffer from vomiting and seizures
during this prodromal period. Most patients with smallpox tend
to be severely ill and bedridden during the febrile prodrome.
The prodromal period is followed by enanthemas (lesions on the
mucosa of the mouth or pharynx), which may not be noticed by
the patient. This stage occurs less than 24 hours before the
onset of rash, which usually is the first recognized manifestation
of infectiousness. With the onset of enanthemas, the patient
becomes infectious and remains so until all skin crust lesions
have separated. The exanthem, or rash, typically begins on the
face and rapidly progresses to involve the forearms, trunk,
and legs in a centrifugal distribution (greatest concentration
. . . [Go to Full Text]
This topic has been referenced by these articles:
- Abramson, J. S., McMillan, J. A., Baltimore, R. S.
(2003). The US Smallpox Vaccination Plan. Pediatrics
111: 1431-1432
[Full Version]
- Puliyel, J. M.
(2002). The Dummies' Guide to Risk-Benefit Analysis of Vaccines. Pediatrics
110: 193-193
[Full Version]
- Committee on Infectious Diseases,
(2002). Smallpox Vaccine. Pediatrics
110: 841-845
[Abstract]
[Full Version]
- Wood, R. A.
(2004). RESPONSE TO SMALLPOX VACCINE IN PERSONS IMMUNIZED IN THE DISTANT PAST. Pediatrics
114: 553-553
[Full Version]
- Raju, T. N.K.
(2006). Hot Brains: Manipulating Body Heat to Save the Brain. Pediatrics
117: e320-e321
[Full Version]
- Stiehm, E. R.
(2006). Disease Versus Disease: How One Disease May Ameliorate Another. Pediatrics
117: 184-191
[Abstract]
[Full Version]
- Patt, H. A., Feigin, R. D.
(2002). Diagnosis and Management of Suspected Cases of Bioterrorism: A Pediatric Perspective. Pediatrics
109: 685-692
[Abstract]
[Full Version]
- Historical Archives Advisory Committee,
(2001). Committee Report: American Pediatrics: Milestones at the Millennium. Pediatrics
107: 1482-1491
[Full Version]
- American Academy of Pediatrics,
(2006). AAP Publications Retired and Reaffirmed. Pediatrics
117: 1846-1847
[Full Version]